Corporate News 26-Apr-24
Solara Active Pharma Sciences completes divestment of 100% stake in SeQuent Penems
Solara Active Pharma Sciences has completed the sale of 100% stake in SeQuent Penems to Symbio Generrics India for a cash consideration of Rs.12.50 crore on 25 April 2024. Hence, SeQuent Penems ceased to be a subsidiary of the Company.
Previous News
Solara Active Pharma Sciences fixes record date for interim dividend
( Market Beat - Reports 11-Nov-20 12:54 )
Solara Active Pharma Sciences consolidated net profit declines 47.57% in the September 2021 quarter
( Results - Announcements 13-Nov-21 08:29 )
Solara Active Pharma Sciences completes WHO inspection at its Cuddalore facility
( Corporate News - 27-Jan-23 10:16 )
Solara Active Pharma Sciences to discuss results
( Corporate News - 01-Aug-22 11:38 )
Solara Active Pharma Sciences schedules board meeting
( Corporate News - 08-Nov-21 12:20 )
Solara Active Pharma Sciences consolidated net profit declines 32.29% in the March 2020 quarter
( Results - Announcements 07-May-20 15:02 )
Solara Active Pharma Sciences to hold board meeting
( Corporate News - 09-Nov-20 13:41 )
Solara Active Pharma Sciences to table results
( Corporate News - 06-Feb-24 17:03 )
Board of Solara Active Pharma Sciences recommends final dividend
( Corporate News - 07-May-20 17:24 )
USFDA classifies Solara's Cuddalore facility as Official Action Indicated
( Corporate News - 23-Jun-20 10:41 )
Solara Active Pharma tumbles after Q4 PAT falls 32% to Rs 17.80 cr
( Hot Pursuit - 07-May-20 15:16 )
Other Stories
GAIL (India) signs MoU with AM Green
04-Oct-24 19:27
EaseMyTrip.com resumes bookings to the Maldives
04-Oct-24 19:25
BLS completes acquisition of Dubai-based Citizenship Invest
04-Oct-24 19:23
Insecticides India launches new maize herbicide 'Torry Super'
04-Oct-24 19:21
Landmark Cars receives LoI from Mercedes-Benz India
04-Oct-24 19:19
Astra Microwave Products receives affirmation in credit ratings from CRISIL
04-Oct-24 19:16
Supreme Petrochem receives affirmation in credit ratings
04-Oct-24 19:10
Astec LifeSciences director resigns
04-Oct-24 19:08
Board of Gravita India approves change in directorate
04-Oct-24 19:05
Board of Gravita India approves fund raising up to Rs 1,000 cr
04-Oct-24 19:03
Back
Top
